Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels

December 16, 2010 By Bio-Medicine.Org

WAYNE, N.J., Dec. 16, 2010 /PRNewswire/ — Bayer HealthCare
Pharmaceuticals, Inc. today announced the U.S. Food and Drug
Administration (FDA) has approved a new oral contraceptive (OC),
SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/
levomefolate calcium 451 mcg tablets and levomefolate calcium 451
mcg tablets).  In women who choose an OC for birth control,
SAFYRAL raises folate levels for the purpose of reducing the risk
of rare neural tube defects (NTDs) in a pregnancy conceived while
taking SAFYRAL or shortly after discontinuing it.  SAFYRAL
provides the birth control YASMIN® (drospirenone 3 mg/ ethinyl
estradiol 30 mcg) with 451 mcg levomefolate calcium, which
is a B vitamin.

SAFYRAL is the second Bayer OC which contains folate.  In
September, the FDA approved Beyaz™ (drospirenone 3 mg/
ethinyl estradiol 20 mcg/ levomefolate calcium 451 mcg tablets and
levomefolate calcium  451 mcg tablets), the first OC approved
by the FDA to raise folate levels in women who choose an OC for
birth control.

“With the FDA approval of Safyral, Bayer now offers two oral
contraceptives that contain folate,” said Leslie North, Vice
President of Marketing, Women’s HealthCare, Bayer HealthCare
Pharmaceuticals.  “SAFYRAL and Beyaz are part of Bayer’s
growing women’s health franchise, and these new products reinforce
our commitment to providing women various contraceptive
options.”

The Centers for Disease Control and Prevention, the U.S.
Preventive Services Task Force, the March of Dimes and other
leading health authorities recommend that all women of childbearing
age supplement their diet with at least 400 mcg of folic acid
daily.(1),(2),(3)  A well-established body of evidence
supports folate supplementation as a means to reduce the incidence
of neural tube defects  – rare birth defects of the
brain and spinal cord.(2),(3),(4)  These rare birth defects
happen in the first few weeks of p

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
DeepWell Digital Therapeutics Mike Wilson Ryan Douglas
How DeepWell is developing video games as tools for treating medical conditions
A woman with a small, handheld device in her lap with tubes that look like earphones plugged into her ears.
Ear-puffing device for migraine treatment wins FDA breakthrough designation
Abbott
Abbott launches upgraded digital health app for neurostimulation

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech